Clinical Trial Update: A Study of Enasidenib in People With Clonal Cytopenia of Undetermined Significance [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating Enasidenib in people with Clonal Cytopenia of Undetermined Significance (CCUS) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clonal Cytopenia of Undetermined Significance

Drugs mentioned

• Enasidenib (enasidenib)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Clonal Cytopenia of Undetermined Significance, CCUS Clonal Cytopenia of Undetermined Significance | Phase 1 | Status: COMPLETED